- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07576218
Effects of Pilates and Progressive Prone Plank Exercises in Diastasis Recti
Comparative Effects of Pilates and Progressive Prone Plank Exercises on Pain, Strength and Inter-Rectus Distance in Diastasis Recti
This study aims to determine the comparative effects of Pilates and Progressive Prone Plank exercises on pain, strength and inter rectus distance in Diastasis Recti
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This will be a randomized clinical trial collected from University of Lahore Teaching hospital and Sehat Medical Complex Lahore by using non-probability convenience sampling technique. Multiparous women with a BMI less than 30 kg/m² and have been clinically diagnosed with Diastasis Recti will be included in this study. Participants must be able to perform physical activity without contraindications and must provide informed consent. Women currently pregnant, with significant pelvic floor dysfunction, unmanaged chronic illnesses (e.g., heart disease or hypertension), recent abdominal surgeries within the last six months will be excluded. The sample size is calculated to be 34, with 17 participants in each group. Group A will receive Pilates training, while Group B will undergo progressive prone plank exercises. Each session will last for 45 minute, thrice weekly for four weeks. Pre- and post-treatment evaluations will include pain (Numeric Pain Rating Scale), strength (Manual Muscle Testing), and inter-rectus distance (measured by finger-width method with a Vernier caliper). Data will be analyzed by using SPSS version 27.0.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: imran amjad
- Phone Number: 03324390125
- Email: imran.amjad@riphah.edu.pk
Study Locations
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 6400
- Recruiting
- Sehat Medical Complex
-
Contact:
- sobia ghafoor, MSPT-OM
- Email: Sobia.physio@gmail.com
-
Principal Investigator:
- Rameesha khan, MSPT(WH)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Multiparous women
- Postpartum women (within 6 to 12 months postpartum)
- BMI <30
- IRD ≥2 cm diagnosed with Diastasis Recti (verified by ultrasound or clinical assessment)
- Participants who have undergone either vaginal delivery or cesarean section (C-section).
Exclusion Criteria:
- Significant pelvic floor dysfunction or pelvic organ prolapse or other related conditions
- Patient with unmanaged chronic conditions, like heart disease or hypertension
- Recent abdominal or related surgeries within the past six months
- Women who are currently pregnant or experiencing postpartum complications.
- Patient with presence of hernia.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Pilates exercises
All exercises in the Pilates training group will be performed on a mat in a controlled environment under the supervision of a qualified instructor. The focus will be on core activation, controlled breathing, and maintaining neutral spine alignment throughout all movements |
It will be delivered three times per week for four weeks, with each session lasting approximately 25 minutes |
|
Experimental: Progressive Prone Plank Exercises
Participants will follow a structured progressive prone plank protocol designed to strengthen the core muscles, particularly targeting the transverse abdominus and rectus abdominus, which are crucial in managing Diastasis Recti. All exercises will be performed under supervision, with emphasis on correct posture, controlled breathing, and spinal alignment |
It will be delivered three times per week for four weeks, with each session lasting approximately 25 minutes |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Numeric Pain Rating Scale (NPRS)
Time Frame: 4th week
|
The Numerical Pain Rating Scale (NPRS) is a widely used subjective pain measurement tool. It was created as a simple way to assess pain severity. It has a rating range of 0 to 10, with 0 representing no pain, 5 indicating severe discomfort, and 10 denoting the greatest conceivable agony |
4th week
|
|
Manual muscle testing
Time Frame: 4th week
|
Manual muscle testing (MMT) is a fundamental assessment method used by healthcare professionals to evaluate muscle strength, including the gluteus medius and gluteus maximus. (34) It has a scoring range from 0 to 5 where 5 shows maximum strength. It has a reliability range from 0.88 to 0.94. It also has a good validity with 0.62 to 1.00 range |
4th week
|
|
Finger width method
Time Frame: 4th week
|
In this patient were asked to lie in a supine position in crook lying. Patient is instructed to do abdominal crunch till their shoulder is off the couch. By palpation around the protrusion along the linea alba diastasis recti is assessed with 4.5 cm above and below of umbilical. In case of less than 2 fingers breadth there is no diastasis recti. In case of 2 to 3 fingers breadth the diastasis recti is considered mild. In case of 3 to 4 fingers breadth it is considered as moderate and in case of 4 or more than 4 fingers breadth the diastasis recti is considered severe. The measurement will be done with the help of a Vernier caliper. Measurements were taken 4.5 cm above and below the umbilicus during an abdominal crunch, with the caliper placed between the palpated borders of the rectus abdominis. Three readings were taken at each point, and the average was used for analysis |
4th week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: sobia ghafoor, MSPT-OM, Riphah International University
Publications and helpful links
General Publications
- Tung RC, Towfigh S. Diagnostic techniques for diastasis recti. Hernia. 2021 Aug;25(4):915-919. doi: 10.1007/s10029-021-02469-7. Epub 2021 Jul 27.
- Cavalli M, Aiolfi A, Bruni PG, Manfredini L, Lombardo F, Bonfanti MT, Bona D, Campanelli G. Prevalence and risk factors for diastasis recti abdominis: a review and proposal of a new anatomical variation. Hernia. 2021 Aug;25(4):883-890. doi: 10.1007/s10029-021-02468-8. Epub 2021 Aug 6.
- Gluppe S, Ellstrom Engh M, Bo K. Primiparous women's knowledge of diastasis recti abdominis, concerns about abdominal appearance, treatments, and perceived abdominal muscle strength 6-8 months postpartum. A cross sectional comparison study. BMC Womens Health. 2022 Nov 2;22(1):428. doi: 10.1186/s12905-022-02009-0.
- Lin S, Lu J, Wang L, Zhang Y, Zhu C, Qian S, Xu H, Gu Y. Prevalence and risk factors of diastasis recti abdominis in the long-term postpartum: a cross-sectional study. Sci Rep. 2024 Oct 27;14(1):25640. doi: 10.1038/s41598-024-76974-x.
- Fuentes Aparicio L, Rejano-Campo M, Donnelly GM, Vicente-Campos V. Self-reported symptoms in women with diastasis rectus abdominis: A systematic review. J Gynecol Obstet Hum Reprod. 2021 Sep;50(7):101995. doi: 10.1016/j.jogoh.2020.101995. Epub 2020 Nov 20. No abstract available.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC/RCR & AHS/25/0503
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.